29 Aug
2021

Top IP dealmakers named; BlackBerry patent sale soon; In defence of Michelle Lee; Toyota nets Lyft portfolio; IAM parent acquires Docket Navigator; plus much more

Everything we covered on IAM over the last seven days – and all you need to know from the global IP market to set yourself up for the start of another busy week

The Long Read

Grounded at home and facing an uncertain transactions environment, IP business leaders still found ample opportunities to make innovative deals during the covid pandemic. We name the individuals sitting in places 40 down to 11 in this year's IAM Market Makers ranking. Read more here

MONDAY 23 August

Woven Planet, the subsidiary leading Toyota’s self-driving push, acquires a raft of global patent assets from ride-hailing app Lyft. Read more here

An ITC judge has found that Google infringed five Sonos patents, but public interest arguments and a workaround could render any import ban the speaker company secures toothless. Read more here

TUESDAY 24 August

Maxell has sued Vizio for infringement of seven US patents, including some obtained just three months ago in a transaction with Chinese TV maker Hisense. Read more here

District of Delaware court decision clears the way for AbbVie to repeat Humira patent thicketing strategy and to generate billions of dollars in Imbruvica sales well into the next decade. Read more here

WEDNESDAY 25 August

IAM’s parent company, Law Business Research, has acquired market-leading US patent litigation data and analytics firm Docket Navigator. Read more here

With quintuple damages for wilful IP violations now available in China, putting alleged patent infringers on notice with a warning letter may well pay dividends - but there are dangers too. Read more here

THURSDAY 26 August

Despite growth in the Chinese patent profession, it is a competitive market for high-quality services and many places remain keen to attract talent. Read more here

Pfizer’s $2.3 billion acquisition of cutting-edge immuno-therapy inventions is the most recent development in the booming oncology IP market. Read more here

Former acting deputy director of the USPTO, Coke Stewart, comes to the defence of “brilliant” Michelle Lee, the much-criticised director of the agency between 2015 and 2017. Read more here

FRIDAY 27 August

JinKo Solar, the world’s second-biggest solar panel manufacturer, says it has largely neutralised the threat from a global patent battle that has engulfed several top Chinese firms. Read more here

The FDA has approved the US’s first interchangeable biosimilar. The launch of more such drugs in the coming years will fundamentally alter the biosimilar patent playbook. Read more here

Nine months after IAM first broke the story of a potential sale of BlackBerry’s patent portfolio, the deal to get it done may now be entering its endgame. Read more here

SATURDAY 28 August

Industry insiders are increasingly concerned about how things are going to play out in the realm of connectivity standards setting - and rightly so. Read more here

Joff Wild

Author | Editor-in-chief

[email protected]

Joff Wild